Finanzen von Omada Health Inc (OMDA)OMDAOmada Health Inc

Evaluating the bottom line, Omada Health, Inc. maintains a gross margin of 72.62%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 4.04%, while the net margin is 6.03%. These profitability ratios, combined with a Return on Equity (ROE) of 1.84%, provide a clear picture of how effectively OMDA converts its operational activities into shareholder value.

In the context of the broader market, OMDA competes directly with industry leaders such as LZ and YELP. With a market capitalization of $1.18B, it holds a significant position in the sector. When comparing efficiency, OMDA's gross margin of 72.62% stands against LZ's 68.16% and YELP's 84.05%. Such benchmarking helps identify whether Omada Health, Inc. is trading at a premium or discount relative to its financial performance.

Omada Health has demonstrated strong revenue growth, with Q2 2026 revenue at $87.84 million, reflecting a solid increase from previous quarters. The gross margin has also improved, reaching 72.62% in Q2 2026, indicating effective cost management and profitability potential.